Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZNF382 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF382 mRNA | CTD | PMID:22079256 | ZNF382 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp382 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP382 mRNA | CTD | PMID:21570461 | ZNF382 | Human | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Zfp382 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP382 mRNA | CTD | PMID:36041667 | ZNF382 | Human | 5-aza-2'-deoxycytidine | multiple interactions | EXP | | 6480464 | Decitabine inhibits the reaction [Smoke results in decreased expression of ZNF382 mRNA] | CTD | PMID:21095227 | ZNF382 | Human | acrylamide | increases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Acrylamide results in increased expression of ZFP382 mRNA | CTD | PMID:30807115 | ZNF382 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ZNF382 mRNA | CTD | PMID:32234424 | ZNF382 | Human | ammonium chloride | affects expression | ISO | Zfp382 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of ZFP382 mRNA | CTD | PMID:16483693 | ZNF382 | Human | amphetamine | decreases expression | ISO | Zfp382 (Rattus norvegicus) | 6480464 | Amphetamine results in decreased expression of ZFP382 mRNA | CTD | PMID:30779732 | ZNF382 | Human | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of ZNF382 promoter | CTD | PMID:23974009 | ZNF382 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of ZNF382 5' UTR | CTD | PMID:27901495 | ZNF382 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ZNF382 mRNA | CTD | PMID:32234424 | ZNF382 | Human | bisphenol A | multiple interactions | ISO | Zfp382 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP382 mRNA and [bisphenol A co-treated with Testosterone] results in decreased expression of ZFP382 mRNA | CTD | PMID:26496021 and PMID:36041667 | ZNF382 | Human | bisphenol A | decreases expression | ISO | Zfp382 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of ZNF382 mRNA | CTD | PMID:25181051 | ZNF382 | Human | bisphenol F | multiple interactions | ISO | Zfp382 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of ZFP382 mRNA | CTD | PMID:36041667 | ZNF382 | Human | cadmium atom | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF382 mRNA | CTD | PMID:35301059 | ZNF382 | Human | cadmium dichloride | multiple interactions | EXP | | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ZNF382 mRNA | CTD | PMID:35301059 | ZNF382 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF382 gene] | CTD | PMID:28238834 | ZNF382 | Human | chlorpyrifos | decreases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of ZFP382 mRNA | CTD | PMID:37019170 | ZNF382 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ZNF382 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of ZNF382 mRNA | CTD | PMID:29803840 | ZNF382 | Human | furan | increases methylation | ISO | Zfp382 (Rattus norvegicus) | 6480464 | furan results in increased methylation of ZFP382 gene | CTD | PMID:22079235 | ZNF382 | Human | Licochalcone B | increases expression | EXP | | 6480464 | licochalcone B results in increased expression of ZNF382 mRNA | CTD | PMID:33647349 | ZNF382 | Human | N-Nitrosopyrrolidine | decreases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in decreased expression of ZNF382 mRNA | CTD | PMID:32234424 | ZNF382 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of ZNF382 mRNA | CTD | PMID:23195993 | ZNF382 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of ZNF382 mRNA | CTD | PMID:22714537 | ZNF382 | Human | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of ZNF382 mRNA | CTD | PMID:26272509 | ZNF382 | Human | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF382 mRNA | CTD | PMID:27188386 | ZNF382 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ZNF382 mRNA | CTD | PMID:22230336 | ZNF382 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of ZNF382 mRNA | CTD | PMID:26272509 | ZNF382 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF382 mRNA | CTD | PMID:27188386 | ZNF382 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ZNF382 mRNA | CTD | PMID:22079256 | ZNF382 | Human | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of ZNF382 mRNA | CTD | PMID:22079256 | ZNF382 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | ZNF382 | Human | silver atom | increases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Silver results in increased expression of ZFP382 mRNA | CTD | PMID:27131904 | ZNF382 | Human | silver(0) | increases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Silver results in increased expression of ZFP382 mRNA | CTD | PMID:27131904 | ZNF382 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of ZNF382 mRNA | CTD | PMID:22714537 | ZNF382 | Human | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of ZNF382 mRNA | CTD | PMID:34581912 | ZNF382 | Human | testosterone | multiple interactions | ISO | Zfp382 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Testosterone] results in decreased expression of ZFP382 mRNA | CTD | PMID:26496021 | ZNF382 | Human | thimerosal | decreases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Thimerosal results in decreased expression of ZFP382 mRNA | CTD | PMID:24675092 | ZNF382 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of ZNF382 mRNA | CTD | PMID:25979313 | ZNF382 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF382 mRNA | CTD | PMID:23179753 more ... | ZNF382 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF382 mRNA | CTD | PMID:27188386 | ZNF382 | Human | zinc atom | increases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Zinc results in increased expression of ZFP382 mRNA | CTD | PMID:31505237 | ZNF382 | Human | zinc(0) | increases expression | ISO | Zfp382 (Mus musculus) | 6480464 | Zinc results in increased expression of ZFP382 mRNA | CTD | PMID:31505237 | |